who else can we blame? , page-25

Hi, Thanks for the long post. i dont have time to give aproper reply, but sorry I dont follow TIS so I had completely forgotten them. I am sure they are very good. But I hold AVH thats enough regenerative skin in the game for me.

Alchemia was started in Brisbane by Tracey RAMSDALE its first CEO. Meditech MTD was the company that was formed for HyAct. Faded memory says company was backed from Perth. Science based in Melbourne.

Yes I do like this sector. And sorry if my views upset you, when I am baying for blood. I have posted here several times, I personally dont beleive the senior echelon have enough grunt to do the heavy lifting here.

PS might have done a fine job of setting up HYACT trials. In fact that is not in question. But my experience says a lot of people get promoted far beyond their ability. When that happens it destroys the person and the company. A very common mistake. I am not close enough to form an opinion on his ability at all.

I am sure he is a great bloke with a lot of talent and hard working. That is not my issue. My issue goes back some time here. The market seems to agree with my sentiment.

All these years and all this money to end up here at .28 cents is crazy.

Nobody has picked the woman I referred to earler correct, lets drop the subject she has gone, so no point in pursuing it.

My point was not of criminality it was of competance in Brisbane Bios over the years. Too many Directors promoted well above their ability to do the job. Brisbane had the research institutions throwing up good science, but did not have the business community expertise needed to commercialise the science.

That has been a major problem right across the sector. Luckily the landscape has changed considerably in the investors favour lately and lots of foreign talent has been bolstering our boards.

So I in no way want to single out any body and blame them. But shareholders do need to ring the bell and wake a few people up here.